Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

A prototype assay to detect vCJD-infected blood.

Gregori L.

Lancet. 2011 Feb 5;377(9764):444-6. doi: 10.1016/S0140-6736(11)60057-3. No abstract available.

PMID:
21295340
[PubMed - indexed for MEDLINE]
2.

Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.

Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, Jackson GS.

Lancet. 2011 Feb 5;377(9764):487-93. doi: 10.1016/S0140-6736(10)62308-2.

PMID:
21295339
[PubMed - indexed for MEDLINE]
Free Article
3.

Scientists race to develop a blood test for vCJD.

[No authors listed]

Nat Med. 2001 Mar;7(3):261. No abstract available.

PMID:
11231599
[PubMed - indexed for MEDLINE]
4.

Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.

Brown P, Cervenáková L, Diringer H.

J Lab Clin Med. 2001 Jan;137(1):5-13. Review. No abstract available. Erratum in: J Lab Clin Med 2001 Apr;137(4):230.

PMID:
11150018
[PubMed - indexed for MEDLINE]
5.

A highly specific blood test for vCJD.

Jackson GS, Burk-Rafel J, Edgeworth JA, Sicilia A, Abdilahi S, Korteweg J, Mackey J, Thomas C, Wang G, Mead S, Collinge J.

Blood. 2014 Jan 16;123(3):452-3. doi: 10.1182/blood-2013-11-539239. No abstract available.

PMID:
24434999
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

British study will assess risks of vCJD blood transmission.

Butler D.

Nature. 1997 Nov 13;390(6656):105. No abstract available.

PMID:
9367139
[PubMed - indexed for MEDLINE]
7.

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG.

Lancet. 2004 Feb 7;363(9407):417-21.

PMID:
14962520
[PubMed - indexed for MEDLINE]
8.

Blood-transmitted prions and variant Creutzfeldt-Jakob disease.

Grady GF, Vyas GN.

Biologicals. 2007 Apr;35(2):75-7. Epub 2007 Feb 20. No abstract available.

PMID:
17317213
[PubMed - indexed for MEDLINE]
9.

Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.

Guntz P, Walter C, Schosseler P, Morel P, Coste J, Cazenave JP.

Transfusion. 2010 May;50(5):989-95. doi: 10.1111/j.1537-2995.2009.02569.x. Epub 2010 Jan 15.

PMID:
20088835
[PubMed - indexed for MEDLINE]
10.

Phase I/II safety study of transfusion of prion-filtered red cell concentrates in transfusion-dependent patients.

Cahill MR, Murphy T, Khan M, Fagan J, Murphy WG.

Vox Sang. 2010 Aug 1;99(2):174-6. doi: 10.1111/j.1423-0410.2010.01330.x. Epub 2010 Mar 22.

PMID:
20345513
[PubMed - indexed for MEDLINE]
11.

Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case.

Green AJ, Andrews MM, Bishop MT, McKenzie JM, McCord Y, Pennington C, Chohan G, Knight RS.

J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1408-9. doi: 10.1136/jnnp.2009.183418. Epub 2010 Jun 18. No abstract available.

PMID:
20562404
[PubMed - indexed for MEDLINE]
12.

Comment on validation of diagnostic criteria for variant Creutzfeldt-Jakob disease.

Lukic A, Mead S, Rudge P, Collinge J.

Ann Neurol. 2011 Jan;69(1):212; author reply 212-3. doi: 10.1002/ana.22273. No abstract available.

PMID:
21280094
[PubMed - indexed for MEDLINE]
13.

Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays.

Cooper JK, Ladhani K, Minor PD.

Vox Sang. 2007 May;92(4):302-10.

PMID:
17456154
[PubMed - indexed for MEDLINE]
14.

Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J.

Lancet. 2001 Jul 21;358(9277):171-80.

PMID:
11476832
[PubMed - indexed for MEDLINE]
15.

Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment.

Sachse C, Groschup MH, Warzok R, Greinacher A.

Eur J Haematol. 2003 Jan;70(1):11-6.

PMID:
12631254
[PubMed - indexed for MEDLINE]
16.

Future uncertain for reliable vCJD screening tests.

Bonn D.

Lancet. 2000 Jul 15;356(9225):228. No abstract available.

PMID:
10963208
[PubMed - indexed for MEDLINE]
17.

Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases.

Völkel D, Zimmermann K, Zerr I, Bodemer M, Lindner T, Turecek PL, Poser S, Schwarz HP.

Transfusion. 2001 Apr;41(4):441-8.

PMID:
11316892
[PubMed - indexed for MEDLINE]
18.

14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein.

Green AJ, Ramljak S, Müller WE, Knight RS, Schröder HC.

Neurosci Lett. 2002 May 10;324(1):57-60.

PMID:
11983294
[PubMed - indexed for MEDLINE]
19.

Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease.

Cervenakova L, Brown P, Soukharev S, Yakovleva O, Diringer H, Saenko EL, Drohan WN.

Electrophoresis. 2003 Mar;24(5):853-9.

PMID:
12627447
[PubMed - indexed for MEDLINE]
20.

Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy.

Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.

Transfusion. 2003 Dec;43(12):1687-94.

PMID:
14641865
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk